National Pension Fund Approves Candidates for KT&G Leadership

Business by 2FIRSTS.ai

Mar.25.2024

National Pension Fund Approves Candidates for KT&G Leadership

Korean National Pension Fund approves Fang Qingwan as KT&G CEO candidate, supports Sun Donghwan as external director candidate.

According to South Korean media Naver, on March 22, the South Korean National Pension Fund, one of the three major shareholders of the tobacco manufacturer KT&G, has approved the appointment of Fang Qingwan as a candidate for the president of KT&G. The Trust Responsibility Professional Committee of the National Pension Fund decided to approve the nomination of Mr. Fang as the president candidate at a meeting on the 21st.

The National Pension Fund holds approximately 6.2% of KT&G's shares, further increasing the likelihood of Chang Won as the new CEO of KT&G. Simultaneously, the National Pension Fund has also decided to support the election of Professor Sun Dong-hwan as an external director candidate.

In the recent KT&G shareholders meeting, a new "cumulative voting system" was introduced, allowing each shareholder to freely cast 2 votes per share. The National Pension Fund plans to cast one vote for candidate Bang Gwang-wan and one vote for candidate Son Dong-hwan.

Professor Sun Donghuan has been nominated as an external director candidate by corporate bank and activist fund Flashlight Capital Partners (FCP), in an effort to counter the CEO nomination of Fang Qingwan. He is currently competing against Lin Minki, an external director candidate recommended by the KT&G board.

References:

[1] 국민연금, 방경만 사장 선임안 찬성

Also Read:

[1] IBK Corporate Bank Opposes KT&G Executive Appointments

[2] KT&G Launches New HTP Device MIIX UPTOO, Available Nationwide from March 6

[3] KT&G Shareholder Meeting: FCP Supports External Director Candidate

[4] KT&G Holds Shareholders Meeting at Talent Development Center

#Traditional tobacco #Asia #South Korea #Major companies

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative

Lord Strathcarron, a member of the UK House of Lords, has admitted to discussing the government’s Tobacco and Vapes Bill with a relative who holds a senior role at British American Tobacco (BAT). He is advocating amendments to scrap the bill’s core “generational smoking ban” provision, raising questions of potential conflict of interest.

Oct.27

Teen Nicotine Use Surges in Pakistan as Flavoured Vapes Spread Rapidly

Pakistan is experiencing a sharp rise in nicotine use among teenagers, driven by widespread availability of flavoured vapes and e-cigarettes. Cheap, sweet-flavoured devices are easily accessible in major cities, and weak enforcement of age limits has enabled young users to adopt vaping at alarming rates. Activists warn that industry marketing falsely portrays e-cigarettes as “safer,” putting youth at risk of long-term addiction and serious health effects.

Nov.14 by 2FIRSTS.ai

Irish Government Approves Ban on Disposable Vapes and Tightens Nicotine Controls

Irish Government has approved the Public Health (Single Use Vapes) Bill 2025, which will outlaw the sale of disposable e-cigarettes and introduce tighter restrictions on other nicotine products such as pouches. The move follows Northern Ireland’s similar ban earlier in 2025 and aims to protect young people from nicotine addiction.